Author:
Cachovan M.,Hossmann V.,Rieger H.,Schmidtke I.
Publisher
Springer Berlin Heidelberg
Reference181 articles.
1. Acevedo A (1986) Wundheilung und Wundheilungsprobleme. Phlebol Proktol 15: 59
2. Adhoute G, Bacourt F, Barrat M (1986) Naftidrofryl in chronic arterial disease. Results of a six month controlled multicenter study using naftifdrofuryl tablets 200 mg. Angiology 37: 160–167
3. Adhoute G, Andreassian B, Boccalon H, Cloarec M, Di Maria G, Lefebvre O, Mondine P, Plagnol P, Pointel P, Quancard X, Revelin P, Testard J, Thevenet A, Vasseur JJ (1990) Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: Results after 6 month of a controlled multicenter study. J Cardiovas Pharmacol 16 [Suppl 3]: 75–80
4. Amendt K, Hild R (1990) Pharmacokinetics of mezlocillin after intrarterial or intravenous injection in patients with peripheral arterial occlusive disease. VASA 19: 161–166
5. Amendt K, Rexroth W, Römmele U, Stein U, Wagner E, Hild R (1987) Intraarterielle Injektion von Mezlocillin bei arterieller Verschlußkrankheit im Stadium IV. VASA 16: 193